NCT04458909 2025-10-03Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal CancerNational Cancer Institute (NCI)Phase 3 Terminated15 enrolled 17 charts
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT00394147 2022-08-05Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck CancerFox Chase Cancer CenterPhase 2 Terminated17 enrolled 8 charts
NCT02789189 2019-09-06Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase â…¡ Clinical TrailSun Yat-sen UniversityPhase 2 Terminated60 enrolled
NCT00256295 2017-02-01Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck CancerUniversity of California, IrvinePhase 2 Terminated8 enrolled 7 charts
NCT00176241 2015-06-08Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerUniversity of KentuckyPhase 1 Terminated7 enrolled